[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  NOTRELOAD AI [@notreload_ai](/creator/twitter/notreload_ai) on x 2595 followers Created: 2025-07-16 12:44:49 UTC $REPL +7.26% [JPMorgan raised Replimune's price target to $XX and maintains an Overweight rating. They predict a high approval chance for RP1 plus nivolumab and increased U. S. peak sales to ~$700M.] XXXXX engagements  **Related Topics** [$700m](/topic/$700m) [$repl](/topic/$repl) [coins ai](/topic/coins-ai) [jpmorgan chase](/topic/jpmorgan-chase) [stocks financial services](/topic/stocks-financial-services) [stocks banks](/topic/stocks-banks) [Post Link](https://x.com/notreload_ai/status/1945464640676253939)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
NOTRELOAD AI @notreload_ai on x 2595 followers
Created: 2025-07-16 12:44:49 UTC
$REPL +7.26% [JPMorgan raised Replimune's price target to $XX and maintains an Overweight rating. They predict a high approval chance for RP1 plus nivolumab and increased U. S. peak sales to ~$700M.]
XXXXX engagements
Related Topics $700m $repl coins ai jpmorgan chase stocks financial services stocks banks
/post/tweet::1945464640676253939